US Supreme Court weighs case that could hinder cheaper drug manufacturing

By: Medill News Service

Outlets: DC Bureau (States Newsroom)

Published: May 1, 2026

Words: 855

Last Updated: 2 months ago


Body Text Preview

By Zara Norman/Medill News Service

WASHINGTON — John Bailey said he’s saved tens of thousands of dollars over the last decade by relying on a generic prescription to lower his cholesterol.

The 68-year-old from central Texas was able to get a generic because the patent on a brand-name medication expired. He and many other Americans worried that a case the U.S. Supreme Court heard April 29 could restrict access to generic drugs more broadly.

“It’s probably going to …

Create a free account to access this story and more

Join Plucky Wire to access full stories, collaborate with newsrooms, and discover content from networks around the world.

Register for Free Log in